About Virtonomy
Virtonomy is a company based in Munchen (Germany) founded in 2019 by Simon Sonntag and Wen Yang Chu. Virtonomy has raised $3.82 million across 4 funding rounds from investors including Accenture, EIT Health and European Union. Virtonomy offers products and services including v-Patients, Virtual Trial Platform, and Regulatory Services. Virtonomy operates in a competitive market with competitors including Unlearn, Ebenbuild, adsilico, Verto Health and ELEM Biotech, among others.
- Headquarter Munchen, Germany
- Founders Simon Sonntag, Wen Yang Chu
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Virtonomy Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.82 M (USD)
in 4 rounds
-
Latest Funding Round
$3.82 M (USD), Seed
Apr 12, 2023
-
Investors
Accenture
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Virtonomy
Virtonomy offers a comprehensive portfolio of products and services, including v-Patients, Virtual Trial Platform, and Regulatory Services.
Virtual patients for testing medical devices in simulated anatomies.
Platform for full lifecycle support in medical device creation.
Assistance with regulatory compliance and virtual testing plans.
People of Virtonomy
Unlock access to complete
Funding Insights of Virtonomy
Virtonomy has successfully raised a total of $3.82M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $3.82 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Virtonomy
Virtonomy has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Accenture, EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are made in European startups.
|
Locked | Locked | Locked | |
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made in startups.
|
Locked | Locked | Locked |
Investor details for Virtonomy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Virtonomy
Investment portfolio details for Virtonomy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Virtonomy
Detailed financials for Virtonomy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Virtonomy Comparisons
Peer comparison for Virtonomy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Virtonomy
Virtonomy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unlearn, Ebenbuild, adsilico, Verto Health and ELEM Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based clinical trial management software
|
|
| Locked | Locked | Locked |
Digital twin-based precision therapy for ARDS ventilation is provided.
|
|
| Locked | Locked | Locked |
In-silico trial solutions for medical device testing are developed.
|
|
| Locked | Locked | Locked |
A digital twin platform for population health management is offered.
|
|
| Locked | Locked | Locked |
A simulation-based platform for virtual medical trials is provided.
|
Detailed competitors of Virtonomy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Virtonomy
Complete news archive for Virtonomy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virtonomy
Virtonomy was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Virtonomy is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Simon Sonntag is the current CEO of Virtonomy. They have also founded this company.
Virtonomy is a funded company, having raised a total of $3.82M across 4 funding rounds to date.
Provider of virtual patient simulation for medical device development. It offers an end-to-end digital twin and simulation solution based on real clinical data. This allows medical device developers to perform development and testing in a virtual environment, accelerating development, reducing risks and expenses, and lessening regulatory burden. The platform supports the full product life cycle, from concept to regulatory reporting. Simulations include anatomical variability, demographic diversity, and pathological conditions, enabling accurate 3D measurements and advanced statistical shape models. The platform also provides regulatory services and consultation, assisting with the creation of virtual testing plans and compliance with regulatory bodies. Virtual patient data can be used as digital evidence for regulatory submissions.
Virtonomy's top competitors include Unlearn, Ebenbuild and Verto Health.
Virtonomy offers v-Patients, Virtual Trial Platform, and Regulatory Services.
Virtonomy has 9 investors. Key investors include Accenture, EIT Health, European Union, DvH Ventures, and Bayern Kapital.